Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Operating Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹2,435 Cr₹2,387 Cr₹5,016 Cr₹3,329 Cr₹4,381 Cr

What is the latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA is ₹2,435 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹2,435 Cr
Mar2023₹2,387 Cr
Mar2022₹5,016 Cr
Mar2021₹3,329 Cr
Mar2020₹4,381 Cr

How is Cash Flow from Operating Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹2,435 Cr
2.00
Mar2023 ₹2,387 Cr
-52.42
Mar2022 ₹5,016 Cr
50.69
Mar2021 ₹3,329 Cr
-24.02
Mar2020 ₹4,381 Cr -

Compare Cash Flow from Operating Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹66,437.7 Cr -2.3% -4.8% -8.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,420.0 Cr -0.2% -2.9% 12.6% Stock Analytics
DIVIS LABORATORIES ₹177,572.0 Cr 0.3% 6.5% 49% Stock Analytics
CIPLA ₹123,329.0 Cr 1.1% 1.8% -1.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,396.0 Cr -0.2% 9.5% 12.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,956.0 Cr 1.9% 0.4% 14% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-2.3%

-4.8%

-8.4%

SENSEX

-0.8%

-0.9%

6.9%


You may also like the below Video Courses